Motivational Interview to improve vascular health in Adolescents with poorly controlled type 1 Diabetes (MIAD): a randomized controlled trial.
adolescent diabetes
arterial stiffness
intima-media thickness
pediatric type 1 diabetes
Journal
BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
23
01
2020
revised:
05
06
2020
accepted:
16
06
2020
entrez:
30
7
2020
pubmed:
30
7
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
We studied if motivational interviewing (MI) added to standard educational care (SEC) improves vascular health in adolescents with poorly controlled type 1 diabetes. 47 adolescents with type 1 diabetes of at least 2 years duration and hemoglobin A1c >75 mmol/mol (>9.0%) on two visits were randomized to MI+SEC or SEC. We also compared vascular health parameters of patients with type 1 diabetes at trial baseline with a group of healthy historical controls matched for age and body size. 39 adolescents (20 MI+SEC) completed the vascular health study. At 12 months, parameter changes were not statistically significantly different between MI+SEC and SEC (carotid-femoral pulse wave velocity (cfPWV): mean difference 0.052 m/s (95% CI -0.395 to 0.500, p=0.81); carotid-radial PWV (crPWV): 0.118 m/s (95% to 0.478 to 0.713, p=0.69), carotid intima-media thickness (IMT): 0.002 mm (95% CI -0.37 to 0.40, p=0.93), systolic blood pressure (BP) z-score: 0.495 (95% CI -0.099 to 1.09, p=0.10). At baseline, duration of type 1 diabetes was associated with radial IMT (r=0.430, p=0.007) and cfPWV (r=0.373, p=0.018), and carotid, femoral and brachial IMT were correlated with continuous glucose monitoring (CGM) SD (r=0.440, p=0.017; r=0.377, p=0.048; r=0.387, p=0.038). There was an inverse association between CGM time-in-range (3.9-10.0 mmol/L) and crPWV (r=-0.476, p=0.022) changes. Systolic BP change was associated with body mass index change (r=0.374, p=0.019) and IMT change (r=0.461, p=0.016 for carotid IMT; r=0.498, p=0.010 for femoral IMT). PWVs were higher and common carotid compliance lower among patients with type 1 diabetes at baseline compared with healthy controls, but no other differences were found. There was no effect of MI added to SEC on vascular health parameters. Although disease duration and glycemic control were associated with vascular health at baseline, there were only limited associations between glycemic control and vascular health parameter changes. Vascular health parameter changes were interrelated suggesting clustering of cardiovascular risk. NCT02637154.
Identifiants
pubmed: 32723754
pii: 8/1/e001216
doi: 10.1136/bmjdrc-2020-001216
pmc: PMC7388880
pii:
doi:
Substances chimiques
Blood Glucose
0
Banques de données
ClinicalTrials.gov
['NCT02637154']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Diabetes Care. 2013 Dec;36(12):3938-43
pubmed: 24101697
Diabetes Care. 2016 Mar;39(3):418-25
pubmed: 26721813
JAMA. 2003 Oct 22;290(16):2159-67
pubmed: 14570951
Ann Hum Biol. 2012 May;39(3):171-82
pubmed: 22621754
Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2516-24
pubmed: 22837471
Diabetes Care. 2003 Apr;26(4):1052-7
pubmed: 12663572
Diabetes Care. 2005 Aug;28(8):1974-80
pubmed: 16043741
Diabetes Care. 1989 Nov-Dec;12(10):686-93
pubmed: 2612303
N Engl J Med. 2017 Nov 2;377(18):1733-1745
pubmed: 29091568
Ann Med. 2011 May;43(3):235-48
pubmed: 20854213
Diabetologia. 2007 Sep;50(9):1808-1814
pubmed: 17611734
Diabetes Care. 2010 Aug;33(8):1741-3
pubmed: 20484124
Diabetes Care. 2012 Jun;35(6):1219-24
pubmed: 22474040
Circulation. 2018 Mar 20;137(12):1246-1255
pubmed: 29170152
Arch Intern Med. 2009 Jul 27;169(14):1307-16
pubmed: 19636033
Diabetes. 2002 Feb;51(2):493-8
pubmed: 11812760
Pediatr Diabetes. 2012 May;13(3):278-84
pubmed: 22060802
J Diabetes Complications. 2015 May-Jun;29(4):512-6
pubmed: 25736026
Pediatr Diabetes. 2012 May;13(3):251-8
pubmed: 21933316
N Engl J Med. 2005 Jan 27;352(4):341-50
pubmed: 15673800
J Pediatr. 2010 May;156(5):731-7, 737.e1
pubmed: 20097360
Arch Dis Child. 2003 Aug;88(8):680-3
pubmed: 12876161
Eur J Clin Invest. 2014 Nov;44(11):1065-71
pubmed: 25252103
Atherosclerosis. 2010 Oct;212(2):516-23
pubmed: 20673898
Am J Med. 1985 May;78(5):785-94
pubmed: 3993659
Diabetes Care. 2013 Sep;36(9):2597-9
pubmed: 23564920
Curr Diab Rep. 2014 Oct;14(10):531
pubmed: 25142716
Lancet. 2018 Aug 11;392(10146):477-486
pubmed: 30129464
Eur Heart J. 2013 Dec;34(45):3501-7
pubmed: 23821401
Lancet Child Adolesc Health. 2018 Sep;2(9):635-646
pubmed: 30119757
Diabetes Obes Metab. 2014 May;16(5):381-7
pubmed: 23927612
J Hypertens. 2014 Apr;32(4):873-80
pubmed: 24509122
J Pediatr. 2001 Dec;139(6):804-12
pubmed: 11743505
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
Cardiovasc Diabetol. 2011 Jun 16;10:53
pubmed: 21679428
Pediatr Obes. 2012 Aug;7(4):284-94
pubmed: 22715120
BMJ. 2011 Sep 08;343:d5364
pubmed: 21903695
Diabetes Care. 1997 Jan;20(1):77-80
pubmed: 9028699